Alphatec Holdings, Inc. reports results for the quarter ended September 30 - Earnings Summary
Alphatec Holdings, Inc. reports results for the quarter ended September 30 - Earnings Summary
Alphatec Holdings, Inc. ATEC.OQ reported quarterly adjusted earnings of 9 cents per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -19 cents. The mean expectation of thirteen analysts for the quarter was for earnings of 9 cents per share. Wall Street expected results to range from 7 cents to 12 cents per share.
Revenue rose 12.6% to $221.17 million from a year ago; analysts expected $225.15 million.
Alphatec Holdings, Inc.'s reported EPS for the quarter was a loss of 3 cents.
The company reported a quarterly loss of $5.47 million.
Alphatec Holdings, Inc. shares had risen by 10.9% this quarter and lost 45.6% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 1.8% in the last three months.
In the last 30 days, one analyst negatively revised an earnings estimate
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 14 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Alphatec Holdings, Inc. is $15.00, about 24.2% above its last closing price of $11.37
This summary was machine generated from LSEG data October 29 at 10:20 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Sep. 30 2026 | 0.09 | 0.09 | Met |
Jun. 30 2026 | 0.07 | 0.07 | Met |
Mar. 31 2026 | -0.02 | 0.00 | Beat |
Dec. 31 2025 | -0.13 | -0.14 | Missed |
Recent news on Alphatec Holdings
See all newsU.S. RESEARCH ROUNDUP-Bright Minds Biosciences, Marvell Technology, Oracle Corporation
Alphatec Holdings, Inc. reports results for the quarter ended September 30 - Earnings Summary
Alphatec Q3 revenue misses expectations on lower biologics attachment
Brief: Alphatec Q3 Basic EPS USD -0.03
Alphatec Holdings, Inc. expected to post earnings of 9 cents a share - Earnings Preview